Adial Pharmaceuticals (NASDAQ:ADIL) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Adial Pharmaceuticals (ADIL) operate in?

Adial Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Adial Pharmaceuticals Stock (NASDAQ: ADIL) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	16.17K / 148.79K
Day Range	- - -
52 Wk Range	0.77 - 4.17
Market Cap	$6.60M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	1.25%
Days to Cover	1

Recent News

EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use Disorder

Adial Pharmaceuticals completes PK study for AD04 in AUD, meeting FDA requirements and preparing for Phase 3 trial. Data supports 505(b)(2) application.

Vandana Singh

This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

EXCLUSIVE: Adial Pharmaceuticals Secures Additional US Patent Expanding Intellectual Property Protection Around Its Alcohol Use Disorder Candidate

Adial Pharmaceuticals secures a new patent allowance for AD04, enhancing its precision medicine approach for treating alcohol use disorder. Topline results from AD04's latest study are expected in Q4 2024.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	16.17K / 148.79K
Day Range	- - -
52 Wk Range	0.77 - 4.17
Market Cap	$6.60M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	1.25%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Adial Pharmaceuticals (ADIL) stock?

You can purchase shares of Adial Pharmaceuticals (NASDAQ:ADIL) through any online brokerage.

View our list of the best stock brokerages

Who are Adial Pharmaceuticals (ADIL) competitors?

Other companies in Adial Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Gelteq (NASDAQ:GELS), Kiora Pharmaceuticals (NASDAQ:KPRX), Jaguar Health (NASDAQ:JAGX) and Sonoma Pharmaceuticals (NASDAQ:SNOA).

What is the forecast, or price target, for Adial Pharmaceuticals (ADIL) stock?

Adial Pharmaceuticals has a consensus price target of $7.00.

What is the current price for Adial Pharmaceuticals (ADIL)?

The stock price for Adial Pharmaceuticals (NASDAQ: ADIL) is $1.03 last updated November 19, 2024 at 8:07 AM EST.

Does Adial Pharmaceuticals (ADIL) pay a dividend?

There are no upcoming dividends for Adial Pharmaceuticals.

When is Adial Pharmaceuticals (NASDAQ:ADIL) reporting earnings?

Adial Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 13, 2024.

Is Adial Pharmaceuticals (ADIL) going to split?

There is no upcoming split for Adial Pharmaceuticals.

What sector and industry does Adial Pharmaceuticals (ADIL) operate in?

Adial Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Adial Pharmaceuticals

Adial Pharmaceuticals (ADIL) Forecast